1. Market Research
  2. > Pharmaceutical Market Trends
Georgia Pharmaceutical & Healthcare Industries Overview 2017

Georgia Pharmaceutical & Healthcare Industries Overview 2017

  • December 2017
  • 31 pages
  • ID: 5264947
  • Format: PDF
  • By UPharma Consulting


Table of Contents

Search Inside

Georgia Pharmaceutical & Healthcare Industries Overview 2017 provides essential information on the economics, pharmaceutical market, and healthcare landscape in Georgia.

Georgia is located in the South Caucasus region at the crossroads of Southwest Asia and Southeastern Europe. In 2016, Georgia was 119th country in the world by GDP (US$ 14.2 bn). GDP per capita amounted US$ 10,044 (105th position in the world rating).

In 2015 and 2016 the GDP growth slowed to 2.9% and 2.7%, respectively, after the notable fall in exports (23% y-o-y in 2015) due to slowdown of some of the key trade partners (Russia, Azerbaijan, Ukraine). Consumer and business confidence were affected by domestic political uncertainty. 

The average level of inflation reached 2.1% in 2016; however, it grew faster by the end of the year which was mainly due to the increasing amount of GEL in circulation and its depreciation.

In 1990s, pharmaceutical market of Georgia was hugely dependent on imports, while retail sale was controlled by three major pharmacy chains. At the same time the accessibility o? drugs was very low due to low incomes of the population and high cost of imported products.

According to the GeoStat, in 2016 there were 68 producers of pharmaceuticals in Georgia, 295 wholesalers, and 1,014 retailers. The major players on the market are three vertically integrated companies, which include both production, distribution and retail departments. PSP, Aversi and Georgian Healthcare Group (GHG) companies obtain about considerable share of the distribution and retail markets and are able to regulate prices on them.

In 2016, the imports of pharmaceuticals in Georgia reached the maximum value of USD 332 mio growing by 7.4% vs 2015. Main importers of pharmaceuticals in Georgia are companies from Germany, France, Russia, Italy and Turkey.

There are about 1,500 pharmacies in Georgia. About half of them belong to GHG, Aversi and PSP. GHG – 251 PoS, Aversi – 238, PSP – 193. About 700 pharmacies in Georgia are independent i.e. do not belong to any chains. They hold about 15% share of the market. Independent pharmacies predominately are not able to compete with big chains, so their number is decreasing in consequence of bankruptcy and acquisitions.

Foreign companies dominate about 85% of the market in values. The production of local companies is conventionally cheaper, but the quality of it is poorer. In 1H2017, World Medicine (Turkey) was leading company on the Georgian retail pharmaceutical market by sales in values and was followed by Berlin-Chemie/Menarini (Germany) and Servier (France).

In 1H2017, drugs made 96% of total pharmacy sales in values and 98% in volumes. The sales of food supplements made 4% of the total retail sales of pharmacies in values and 2% in volumes. The share of parapharmaceuticals and cosmetics amounted less than 1%.

In nearest years, the boost of the pharmaceutical market of Georgia is not expected. In 2017, we expect it to decrease by 1.9% in values. In 2018 and 2019, some increase stimulated by stable growth of the economy is expected.

The Overview uncovers economic, pharmaceutical and healthcare insights in a tailored made systematic and business styled manner, incl. PESTLE & SWOT analyses, epidemiology & demographic trends.

The report covers a 2012-1HY2017 data with the forecast of the economics and pharmaceutical market growth to 2017-2019.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2020

Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2020

  • $ 4000
  • February 2020

Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2020SummaryMedical Devices sector report, “Sleep Apnea Diagnostic Systems - Medical Devices Pipeline Assessment, 2020" provides an ...

Global Human Microbiome Market - Analysis By Product, By Disease, Application, By Region, By Country : Market Insight, Competition and Forecast

Global Human Microbiome Market - Analysis By Product, By Disease, Application, By Region, By Country : Market Insight, Competition and Forecast

  • $ 2400
  • January 2020

Executive SummaryThe Human Microbiome market was valued at USD 351.81 million in the year 2018. Over the recent years, human microbiome market has been witnessing considerable growth on the back of rising ...

Wounds - Pipeline Review, H2 2019

Wounds - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Wounds - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Pipeline Review, H2 2019, provides an overview of the Wounds (Dermatology) pipeline landscape.Wound ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on